
NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
It is NBE Therapeutics vision to become a leader in antibody-based drug development by developing its own portfolio of drugs until demonstration of a clinical proof-of-concept in man.
Developer of antibody based drugs. The company engages in providing antibody drug conjugates for the treatment of cancer.

Dici NBE Therapeutics sei interessato a lavorare presso la società, pur mantenendo la vostra identità personale anonimo. Comparabilmente darà NBE Therapeutics la possibilità di noleggiare you.When c'è un lavoro di apertura che è una misura faremo la partita accadere.
Inviare loro un invito a valutare la cultura aziendale.